The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis
- PMID: 20303296
- PMCID: PMC2982187
- DOI: 10.1016/j.immuni.2010.03.003
The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis
Abstract
Decreased expression of the Nlrp3 protein is associated with susceptibility to Crohn's disease. However, the role of Nlrp3 in colitis has not been characterized. Nlrp3 interacts with the adaptor protein ASC to activate caspase-1 in inflammasomes, which are protein complexes responsible for the maturation and secretion of interleukin-1beta (IL-1beta) and IL-18. Here, we showed that mice deficient for Nlrp3 or ASC and caspase-1 were highly susceptible to dextran sodium sulfate (DSS)-induced colitis. Defective inflammasome activation led to loss of epithelial integrity, resulting in systemic dispersion of commensal bacteria, massive leukocyte infiltration, and increased chemokine production in the colon. This process was a consequence of a decrease in IL-18 in mice lacking components of the Nlrp3 inflammasome, resulting in higher mortality rates. Thus, the Nlrp3 inflammasome is critically involved in the maintenance of intestinal homeostasis and protection against colitis.
Conflict of interest statement
The authors declare that they have no competing financial interests.
Figures






Comment in
-
Interleukin-18 in intestinal inflammation: friend and foe?Immunity. 2010 Mar 26;32(3):300-2. doi: 10.1016/j.immuni.2010.03.010. Immunity. 2010. PMID: 20346770
-
Mucosal immunology: Inflammasome activation in the gut.Nat Rev Immunol. 2010 May;10(5):293. doi: 10.1038/nri2776. Nat Rev Immunol. 2010. PMID: 20425920 No abstract available.
Similar articles
-
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.Gut. 2010 Sep;59(9):1192-9. doi: 10.1136/gut.2009.197822. Epub 2010 May 4. Gut. 2010. PMID: 20442201
-
Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.Mol Immunol. 2018 Dec;104:11-19. doi: 10.1016/j.molimm.2018.09.004. Epub 2018 Nov 3. Mol Immunol. 2018. PMID: 30396035
-
Activation of the NLRP3 inflammasome by group B streptococci.J Immunol. 2012 Feb 15;188(4):1953-60. doi: 10.4049/jimmunol.1102543. Epub 2012 Jan 16. J Immunol. 2012. PMID: 22250086 Free PMC article.
-
Limited role for ASC and NLRP3 during in vivo Salmonella Typhimurium infection.BMC Immunol. 2014 Aug 13;15:30. doi: 10.1186/s12865-014-0030-7. BMC Immunol. 2014. PMID: 25115174 Free PMC article.
-
The Nlrp3 inflammasome: contributions to intestinal homeostasis.Trends Immunol. 2011 Apr;32(4):171-9. doi: 10.1016/j.it.2011.02.002. Trends Immunol. 2011. PMID: 21388882 Free PMC article. Review.
Cited by
-
Role of HCA2 in Regulating Intestinal Homeostasis and Suppressing Colon Carcinogenesis.Front Immunol. 2021 Feb 23;12:606384. doi: 10.3389/fimmu.2021.606384. eCollection 2021. Front Immunol. 2021. PMID: 33708203 Free PMC article. Review.
-
The interplay between autophagy and ROS in tumorigenesis.Front Oncol. 2012 Nov 21;2:171. doi: 10.3389/fonc.2012.00171. eCollection 2012. Front Oncol. 2012. PMID: 23181220 Free PMC article.
-
Local and systemic effects of microbiome-derived metabolites.EMBO Rep. 2022 Oct 6;23(10):e55664. doi: 10.15252/embr.202255664. Epub 2022 Aug 29. EMBO Rep. 2022. PMID: 36031866 Free PMC article. Review.
-
Esculentoside A Alleviates Intestinal Dysmotility in Ulcerative Colitis by Regulating H2S/CSE and NO/nNOS Systems.Evid Based Complement Alternat Med. 2022 Aug 31;2022:7757833. doi: 10.1155/2022/7757833. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36091585 Free PMC article.
-
Cytokine-Induced Modulation of Colorectal Cancer.Front Oncol. 2016 Apr 19;6:96. doi: 10.3389/fonc.2016.00096. eCollection 2016. Front Oncol. 2016. PMID: 27148488 Free PMC article. Review.
References
-
- Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319–325. - PubMed
-
- Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R, Totsuka T, Takeda K, Akira S, Watanabe M. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol. 2005;40:16–23. - PubMed
-
- Bauer C, Loher F, Dauer M, Mayer C, Lehr HA, Schonharting M, Hallwachs R, Endres S, Eigler A. The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression. Dig Dis Sci. 2007;52:1642–1652. - PubMed
-
- Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–533. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous